Usage Information
Abstract
Traditional polysaccharide vaccines are constrained by streptococcus pneumoniae diversity. We propose a protein-based pneumococcal vaccine (PBPV) — formulated with conserved surface proteins P3296, P5668, PRx1, and pneumolysin (Ply) — that could potentially offer superior immune breadth independent of capsular polysaccharide serotypes. Here, we evaluated the multifunctional antibody responses induced by PBPV, including immunogenicity, Ply neutralization, opsonophagocytic activity (OPA), and such nonopsonic functions as NK cell activation (ADNKA), antibody-dependent cellular phagocytosis, and neutrophil phagocytosis (ADNP) in a cohort of 50- to 69-year-olds. While PBPV showed shorter-lasting immune responses, including reduced Ply-neutralizing capacity, it provided broader cross-serotype protection than 23-valent pneumococcal polysaccharide vaccine. Correlation analysis identified distinct PspA-specific IgG subclass roles: P3296-IgG1 correlated with OPA, and IgG3 correlated with ADNKA/ADNP; P5668-IgG2 correlated with ADNKA/ADNP, and IgG3 correlated with OPA; and PRx1-IgG2 correlated with OPA, and IgG3 correlated with ADNKA. Critically, while no efficacy data have yet confirmed the protective effect of PBPV, its targeting of conserved proteins rather than capsular polysaccharides enables simplified manufacturing and expanded coverage, positioning it as a promising alternative to traditional multipolysaccharide vaccines.
Authors
Kaiyi Li, Jinglu Yang, Xiaobing Zhai, Jinbo Gou, Xiuwen Sui, Bochao Wei, Yuan Wang, Xiaoling Su, Xiaoyun Yang, Shiqin Jin, Xuan Zhou, Yuxuan Zhang, Tao Zhu, Junxiang Wang, Zhongfang Wang
Usage data is cumulative from February 2026 through June 2026.
| Usage | JCI | PMC |
|---|---|---|
| Text version | 1,883 | 195 |
| 567 | 74 | |
| Figure | 564 | 0 |
| Table | 220 | 0 |
| Supplemental data | 375 | 6 |
| Citation downloads | 124 | 0 |
| Totals | 3,733 | 275 |
| Total Views | 4,008 | |
Usage information is collected from two different sources: this site (JCI) and Pubmed Central (PMC). JCI information (compiled daily) shows human readership based on methods we employ to screen out robotic usage. PMC information (aggregated monthly) is also similarly screened of robotic usage.
Various methods are used to distinguish robotic usage. For example, Google automatically scans articles to add to its search index and identifies itself as robotic; other services might not clearly identify themselves as robotic, or they are new or unknown as robotic. Because this activity can be misinterpreted as human readership, data may be re-processed periodically to reflect an improved understanding of robotic activity. Because of these factors, readers should consider usage information illustrative but subject to change.
Copyright © 2026 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)